Picrocrocin exhibits growth inhibitory effects against SK-MEL-2 human malignant melanoma cells by targeting JAK/STAT5 signaling pathway, cell cycle arrest and mitochondrial mediated apoptosis
[et_pb_section bb_built=”1″ _builder_version=”3.0.64″][et_pb_row][et_pb_column type=”4_4″][et_pb_text admin_label=”AUTHORS” _builder_version=”3.0.64″ background_layout=”light” text_orientation=”left” border_style=”solid” text_line_height=”1em”] Lingling Yu, Jing Li, Ming Xiao [/et_pb_text][et_pb_text admin_label=”INSTITUTIONS” _builder_version=”3.0.64″ background_layout=”light” text_orientation=”left” border_style=”solid” text_font_size=”11″] Department of Dermatology of Shanghai Eighth People’s Hospital, Shanghai 200235, China [/et_pb_text][et_pb_text admin_label=”SUMMARY” _builder_version=”3.0.64″ background_layout=”light” text_orientation=”left” border_style=”solid”] SUMMARY Purpose: Melanoma is one of the lethal types of skin malignancies and is